Register to chat with like-minded investors on our interactive forums.
Period:
Draw Mode:
| Volume | 0 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Ocular Therapeutix Inc | OCUL | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 4.645 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 4.645 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0 | - | 1.995 - 11.31 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | 0 | $ 4.645 | USD |
Ocular Therapeutix Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 689.63M | 148.63M | - | 58.44M | -80.74M | -0.54 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Ocular Therapeutix News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical OCUL Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 7.60 | 7.61 | 4.56 | 5.24 | 5,033,270 | -2.96 | -38.88% |
| 1 Month | 9.30 | 9.495 | 4.56 | 6.57 | 2,368,782 | -4.66 | -50.05% |
| 3 Months | 4.95 | 11.31 | 4.56 | 8.19 | 2,450,850 | -0.305 | -6.16% |
| 6 Months | 2.42 | 11.31 | 1.995 | 6.42 | 1,869,731 | 2.23 | 91.94% |
| 1 Year | 6.19 | 11.31 | 1.995 | 5.92 | 1,419,036 | -1.55 | -24.96% |
| 3 Years | 15.52 | 19.84 | 1.995 | 6.71 | 1,078,884 | -10.88 | -70.07% |
| 5 Years | 3.97 | 24.30 | 1.995 | 7.71 | 999,376 | 0.675 | 17.00% |
Ocular Therapeutix Description
| Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Ocular Therapeutix aims to offer medication to replace the existing eye-drop therapy regimen, with the aim of lasting weeks or months with a one-time product application. |
